“We are currently looking at aspects of the rule. As you know there was a three-month delay in implementation of certain compliance dates announced before I arrived at FDA and we are coming up at the end of that delay. Whatever we do in this regard is going to need to be science-based of course. We’re cognizant of the challenges faced by small businesses. I also understand there are a number of legislative measures to exempt premium cigars. If Congress were to act, we would be happy to work with legislators to mitigate any unintended consequences of these measures. I don’t want to comment too specifically given that there is pending litigation right now around this issue, other than to say that I understand the concerns. You (Rubio) and I have had the opportunity to talk about them on a few occasions now. and I do understand the concerns of the small businesses that make premium cigars”